Chunxiu Hu

Dr. Chunxiu Hu

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2018 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
XZXiaohan Zhang
Xiaohan Zhang
WCWenbin Chen
Wenbin Chen
Shanshan ShaoShanshan Shao
Shanshan Shao
GXGuowang Xu
Guowang Xu
YSYongfeng Song
Yongfeng Song
JZJiajun Zhao
Jiajun Zhao


24 November 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
Di YuDi Yu
Di Yu
QXQiuhui Xuan
Qiuhui Xuan
CZChaoqi Zhang
Chaoqi Zhang
Chunxiu HuChunxiu Hu
Chunxiu Hu
YLYanli Li
Yanli Li
Guowang XuGuowang Xu
Guowang Xu
Gliomas are the most aggressive phenotypes of brain tumors and are classified into four grades according to the malignancy degree by the World Health Organization. Metabolic profiling can provide an overview of metabolic reprogramming at a specific stage of tumor initiation and development. Studies about metabolic alterations related to different grades of gliomas are helpful to understand the molecular mechanism for progression of glioma. In the current study, metabolomics and lipidomics analyses based on chromatography-mass spectrometry were performed on different grades of glioma tissues. Differential metabolites between glioma and para-tumor tissues were studied and used as the basis to explore metabolic alterations related to glioma grading. It was found that short-chain acylcarnitines were elevated, whereas lysophosphatidylethanolamines (LPEs) were decreased in high-grade gliomas. Furthermore, the gene expression of short/branched-chain acyl-coenzyme dehydrogenase (ACADSB), which is involved in fatty acid oxidation, was found down-regulated with glioma progression by analyzing related genes and pathways. In addition, LPE metabolism showed a significant difference among different grades of gliomas. These important metabolic pathways related to glioma progression may provide potential clues for further study on the mechanisms and treatment of glioma.

24 April 2020 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
QXQiuhui Xuan
Qiuhui Xuan
FZFujian Zheng
Fujian Zheng
DYDi Yu
Di Yu
YOYang Ouyang
Yang Ouyang
XZXinjie Zhao
Xinjie Zhao
Guowang XuGuowang Xu
Guowang Xu

6 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Andras FrankoAndras Franko
Andras Franko
YSYaping Shao
Yaping Shao
MHMartin Heni
Martin Heni
JHJörg Hennenlotter
Jörg Hennenlotter
MHMiriam Hoene
Miriam Hoene
SLStefan Zoltán Lutz
Stefan Zoltán Lutz
Despite it being the most common incident of cancer among men, the pathophysiological mechanisms contributing to prostate cancer (PCa) are still poorly understood. Altered mitochondrial metabolism is postulated to play a role in the development of PCa. To determine the key metabolites (which included mitochondrial oncometabolites), benign prostatic and cancer tissues of patients with PCa were analyzed using capillary electrophoresis and liquid chromatography coupled with mass spectrometry. Gene expression was studied using real-time PCR. In PCa tissues, we found reduced levels of early tricarboxylic acid cycle metabolites, whereas the contents of urea cycle metabolites including aspartate, argininosuccinate, arginine, proline, and the oncometabolite fumarate were higher than that in benign controls. Fumarate content correlated positively with the gene expression of oncogenic HIF1α and NFκB pathways, which were significantly higher in the PCa samples than in the benign controls. Furthermore, data from the TCGA database demonstrated that prostate cancer patients with activated NFκB pathway had a lower survival rate. In summary, our data showed that fumarate content was positively associated with carcinogenic genes.

22 October 2021 in Molecular Metabolism
Verified
Journal Article
Open access
MHMiriam Hoene
Miriam Hoene
LKLisa Kappler
Lisa Kappler
LKLaxmikanth Kollipara
Laxmikanth Kollipara
Chunxiu HuChunxiu Hu
Chunxiu Hu
MIMartin Irmler
Martin Irmler
Cora WeigertCora Weigert
Cora Weigert
Liver mitochondria adapt to high-calorie intake. We investigated how exercise alters the early compensatory response of mitochondria, thus preventing fatty liver disease as a long-term consequence of overnutrition. We compared the effects of a steatogenic high-energy diet (HED) for six weeks on mitochondrial metabolism of sedentary and treadmill-trained C57BL/6N mice. We applied multi-OMICs analyses to study the alterations in the proteome, transcriptome, and lipids in isolated mitochondria of liver and skeletal muscle as well as in whole tissue and examined the functional consequences by high-resolution respirometry. HED increased the respiratory capacity of isolated liver mitochondria, both in sedentary and in trained mice. However, proteomics analysis of the mitochondria and transcriptomics indicated that training modified the adaptation of the hepatic metabolism to HED on the level of respiratory complex I, glucose oxidation, pyruvate and acetyl-CoA metabolism, and lipogenesis. Training also counteracted the HED-induced glucose intolerance, the increase in fasting insulin, and in liver fat by lowering diacylglycerol species and c-Jun N-terminal kinase (JNK) phosphorylation in the livers of trained HED-fed mice, two mechanisms that can reverse hepatic insulin resistance. In skeletal muscle, the combination of HED and training improved the oxidative capacity to a greater extent than training alone by increasing respiration of isolated mitochondria and total mitochondrial protein content. We provide a comprehensive insight into the early adaptations of mitochondria in the liver and skeletal muscle to HED and endurance training. Our results suggest that exercise disconnects the HED-induced increase in mitochondrial substrate oxidation from pyruvate and acetyl-CoA-driven lipid synthesis. This could contribute to the prevention of deleterious long-term effects of high fat and sugar intake on hepatic mitochondrial function and insulin sensitivity.